Multimodality therapy: Enhancement of melanoma cell death with combination of heat shock protein 90 inhibitor, 17-(Allylamino)-17-demethoxygeldanamycin (17- AAG), and gold nanoparticles in a noninvasive radiofrequency field

Nanotechnology 2010: Bio Sensors, Instruments, Medical, Environment and Energy - Technical Proceedings of the 2010 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2010

Volumn 3, Issue , 2010, Pages 409-411

  Kaluarachchi, Warna D ^a   Curley, Steven A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Hsp; Hyperthermia; Nanoparticles; Radiofrequency

Indexed keywords

17--17-DEMETHOXYGELDANAMYCIN; CANCER CELLS; CLINICAL TRIAL; GOLD NANOPARTICLES; HEAT SHOCK PROTEIN; HEAT THERAPY; HSP; HYPERTHERMIA; MELANOMA CELLS; MULTIMODALITY THERAPY; RADIO FREQUENCIES; RADIO-FREQUENCY FIELDS; RF FIELDS; SKIN CANCERS; SOLID TUMORS; THERAPEUTIC AGENTS;

CELL DEATH; DERMATOLOGY; GOLD; NANOPARTICLES; ONCOLOGY; RADIOFREQUENCY SPECTROSCOPY; SENSORS;

MEDICAL NANOTECHNOLOGY;

EID: 78049432306     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (5)

1. Saida Toshiaki, journal of Dermatological Science, 26, 1-13, 2001.
2. Chemkuri P., Glazer E.S., and Curley S.A., Adv. Drug deli. rev., doi: 10.1016/j.addr.2009.11.006, 2009.
3. Ito A., Saito H., Mitobe K., Minamiya Y., Takahashi N., Maruyama K., Motoyama S., Katayose Y. and Ogawa J., Cancer Science, vol 100, No 3, 558-564, 2009.
4. Curley S. A., Cherukuri P., Briggs K., Patra C. R., Upton M., Dolson E., and Mukherjee P., J Experimental Therapeutics and Oncology, vol. 7, 313-326, 2008.
5. Sven A Lang. Christian Moser, Andreas Gaumann, Dagmar Klein, Gabriel Glockzin, Felix C. Popp, Marc H. Dahlk, Pompiliu Piso, Hans J. Schitt, Edward K Geissler, and Oliver Stoeltzing, Clinical Cancer Research, 13, (21), Nov. 2007.